ApoE4 presents a risk in a gene dose-dependent manner, with ε3/ε4 heterozygotes having a risk increased by three times and ε4/ε4 homozygotes having up to 15 times more chance of developing AD [3]. Here, APOE is linked to Alzheimer disease.